Acadia Pharmaceuticals reported $-45000000 in Operating Profit for its second fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -45M 45M
Adamas Pharmaceuticals ADMS:US $ -7314000 5.79M
Alexion Pharmaceuticals ALXN:US $ -1370.2M 2065.7M
ALKERMES ALKS:US -10667000 22.99M
Alnylam Pharmaceuticals ALNY:US $ -225.2M 26.34M
Biogen BIIB:US $ 1086.4M 888.1M
Biomarin Pharmaceutical BMRN:US $ -40.94M 145.91M
Bristol Myers Squibb BMY:US $ 942M 61M
Cytokinetics CYTK:US $ 5.18M 37.54M
Eisai 4523:JP Y 32120M 20044M
Eli Lilly And LLY:US $ 1196.8M 394M
Gw Pharmaceuticals GWPH:US $ -12.72M 3.68M
Intercept Pharmaceuticals ICPT:US $ -52.03M 31.42M
Johnson & Johnson JNJ:US $ 4401M 461M
Neurocrine Biosciences NBIX:US $ 76M 18M
Pfizer PFE:US $ 3441M 1147M
Prothena PRTA:US -30846000 4.11M
Ptc Therapeutics PTCT:US $ -187.27M 94.28M
Sarepta Therapeutics SRPT:US $ -139M 20M
Seattle Genetics SGEN:US $ 638.19M 732.15M
Ultragenyx Pharmaceutical RARE:US $ -63.06M 57.61M
Vanda Pharmaceuticals VNDA:US $ 9.17M 9.3M
Vertex Pharmaceuticals VRTX:US $ 718.03M 2.19M
YTE INCY:US $ 230.77M 894.78M